The Anatomy of Cutaneous Wound Healing and Its Inhibition: From Mechanisms to Therapy
Marjana Tomic-Canic
DOI: https://doi.org/10.1096/fasebj.2020.34.s1.00372
2020-04-01
The FASEB Journal
Abstract:Cutaneous wound healing integrates multiple cellular processes (inflammation, migration, proliferation, barrier formation, matrix deposition and remodeling; differentiation) and harnesses function of many cell types (keratinocytes, fibroblasts, adipocytes, melanocytes), their cross‐talk to endothelial cells, macrophages, mast cells, platelets, peripheral neurons, local and circulating progenitors with a single goal to repair the tissue and restore barrier. Such organized process is tightly controlled in spatial and temporal manner by using complex signaling networks and micro‐environmental factors. Although this ability of skin to maintain its barrier and heal wounds is evolutionary conserved and maintained throughout a lifetime of an organism, it may fails due to various underlining issues. Chronic wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) represent a widespread unmet clinical challenge and major burden on healthcare systems worldwide. Development of diagnostic tools and treatment strategies is very slow in part due to lack of knowledge regarding the mechanisms of wound healing and its inhibition. We are using genomic approaches and patients’ biopsies to decipher molecular pathophysiology of these chronic wounds as well as molecular mechanisms by which various therapeutic approaches contribute to reprogramming of non‐healing into healing phenotype. Recent findings from primary cells generated from patients as well as transcriptional and mRNA/miRNA profiling revealed multiple new mechanisms that inhibit healing in patients and facilitated identification of wound tissue with repair capability. This chronic wound “genomic signature” includes key mediators of inflammatory response, DNA damage, and response to infection, and specific crosstalk between multiple cell types, revealing new targets and therapeutic approaches. NIH AR060562, NR015649, NR013881 and DK119085
cell biology,biochemistry & molecular biology,biology